Promega corporation:1107424 [19-002032]
Ended Purchase Order Awarded
- Contract number
- 75N95019P00242
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $132,962
Award facts
- Opportunity
-
- Promega-brand assay systems for Tox21 screens Solicitation · 75N95019Q00113 · Posted Mar 26, 2019
- Contract value 100% obligated
- $132,961.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole provider of these proprietary luminescent CYP assays. The contract has no set-aside designation. Promega is a global life sciences company that provides specialized equipment, reagents, and services to federal agencies like NIH, CDC, DoD, and FBI for biological research, diagnostics, and forensics. This order aligns with NCATS' mission to advance translational science and develop new technologies to improve human health.
Quick answers
Who was awarded contract 75N95019P00242?
75N95019P00242 was awarded to Promega Corporation by National Institute on Drug Abuse (National Institutes of Health) on April 9, 2019.
How much is contract 75N95019P00242 worth?
The government has obligated $132,962 on 75N95019P00242.
Which agency awarded contract 75N95019P00242?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019P00242, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95019P00242 competed?
The extent of competition for 75N95019P00242 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award